Genetic Testing Informs Treatment Decisions in Melanoma

Source: Targeted Oncology, May 2021

Novel methods of genetic testing have led to improved detection and better clinical decisions in patients with melanoma, especially in the late-stage setting. However, with multiple tests available, determining when to order a test, which test to order, and exactly how to integrate other immunohistochemistry (IHC) tests into the diagnosis has become a complex question.

READ THE ORIGINAL FULL ARTICLE
Menu